Quentis Therapeutics, Inc Email Format

BiotechnologyNew York, United States11-50 Employees

Quentis Therapeutics, Inc. is a biotechnology research company based in New York City, United States, with a workforce of 11 to 50 employees. The company aims to translate novel biology into therapies that address endoplasmic reticulum (ER) stress across multiple diseases, starting with cancer. Its lead program is a first-in-class inhibitor of IRE1α, designed to target ER stress pathways and stimulate the immune system to attack cancer cells. Quentis was founded by a team with extensive experience in drug discovery and development and positions itself as a New York City-based organization focused on scientific advancement and patient impact. The company has engaged in external financing, including a Series A round completed in 2018 led by Versant Ventures and Polaris Partners.

Sign up for free to view info

Company overview Employee directory